Summary
Patrick Emedom-nnamdi is the founder and CEO of Olira, a company that connects care teams to the complete patient story and delivers predictive clinical intelligence to inform decisions. He is a fourth-year Harvard biostatistics PhD candidate specializing in statistical machine learning and digital phenotyping, supported by the Harvard Prize Fellowship and the T32 Cancer Training Grant. His research aims to learn behavioral patterns and treatment strategies that improve post-intervention recovery using reinforcement learning and latent state space models, leveraging smartphone-derived data to quantify activity, mobility, and clinical outcomes. His career spans roles from DeepMind research scientist to teaching fellow at Harvard and the Blavatnik Fellow in Life Science Entrepreneurship at HBS, reflecting a strong blend of research depth and startup experience. Olira's backers include Plug and Play, Dria Ventures, Precursor Ventures, Black Tech Nation Ventures, and AI angels Jeff Dean and Jonathan Frankle, signaling robust investor validation for data-driven healthcare. Based in New York, he bridges academia and entrepreneurship, translating rigorous biostatistics into scalable, real-world solutions.
10 years of coding experience
6 years of employment as a software developer
Master of Arts - AM, Biostatistics, Master of Arts - AM, Biostatistics at Harvard University
Seton Hall Preparatory School
Bachelor of Arts (BA), Mathematical Biology | Minor: Mathematics | Spanish Language Certificate, Bachelor of Arts (BA), Mathematical Biology | Minor: Mathematics | Spanish Language Certificate at University of Pennsylvania
Igbo, Spanish, English